Macomics

Developer of immnotherapies for treating cancer

placeEdinburgh, Scotland, United Kingdom calendar_todayFounded 2018 groups2 employees language macomics.com

Registered entities

Social engagement

Social engagement: 2.4K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include Epidarex Capital.

Investor typeCountShare
Venture capital117%
Private equity117%
Other / undisclosed467%

Recent activity

19 Dec 2025
Event
JP Morgan/@Biotech Showcase Week
25 Nov 2025
Partnership
ENIGMAC
3 Nov 2025
Event
BioEurope
Coming soon